Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-23 Disposition | 2023-08-25 7:10 pm | N/A 2032-01-23 | Apexigen Inc. | APGN | Hsu Frank J. Chief Medical Officer | 268,226 | $0 | 0 (Direct) | View |
| 2023-06-15 Tax Withholding | 2023-06-23 5:51 pm | N/A N/A | Apexigen Inc. | APGN | Hsu Frank J. Chief Medical Officer | 4,323 | $0.4911 | 16,354 (Direct) | View |
| 2022-12-15 Tax Withholding | 2022-12-19 5:41 pm | N/A N/A | Apexigen Inc. | APGN | Hsu Frank J. Chief Medical Officer | 4,323 | $1.06 | 20,677 (Direct) | View |
| 2022-10-07 Option Award | 2022-10-11 4:53 pm | N/A 2032-10-07 | Apexigen Inc. | APGN | Hsu Frank J. Chief Medical Officer | 52,000 | $0 | 52,000 (Direct) | View |
Ownership | 2022-08-08 4:56 pm | N/A 2032-01-23 | Apexigen Inc. | APGN | Hsu Frank J. Chief Medical Officer | 0 | $0 | 224,872 (Direct) | View |
| 2020-03-17 Option Award(A) | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | Hsu Frank J. Chief Medical Officer | 16,280 | $0 | 16,280 (Direct) | View |
| 2019-08-26 Option Award(A) | 2020-07-31 9:05 pm | N/A 2029-08-26 | Oncternal Therapeutics Inc. | ONCT | Hsu Frank J. Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-18 6:48 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | Hsu Frank J. Chief Medical Officer | 16,280 | $0 | 16,280 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-28 5:48 pm | N/A 2029-08-26 | Oncternal Therapeutics Inc. | ONCT | Hsu Frank J. Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |